Domov › Kronična limfocitna levkemija › Distrikta Columbia › Washington
Klinične študije za Kronična limfocitna levkemija v Washington, DC
22 študij za Kronična limfocitna levkemija išče udeležence na lokacijah v Washington in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
Vključevanje udeležencevFaza 1/2
- American Oncology Partners of Maryland Pa, Bethesda · 7 mi stran
A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
Vključevanje udeležencevFaza 3
- Center for Cancer and Blood Disorders ( Site 5439), Bethesda · 7 mi stran
Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
Vključevanje udeležencevOpazovalna študija
- National Institutes of Health Clinical Center, Bethesda · 7 mi stran
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · 7 mi stran
A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
Vključevanje udeležencevFaza 3
- GC2202 Study Site 111, Bethesda · 7 mi stran
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Vključevanje udeležencevFaza 3
- Sibley Memorial Hospital, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · 7 mi stran
A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
Vključevanje udeležencevFaza 3
- American Oncology Partners of Maryland Pa, Bethesda · 7 mi stran
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Vključevanje udeležencevFaza 3
- Medstar Georgetown University Hospital, Washington D.C.
Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)
Vključevanje udeležencevOpazovalna študija
- National Institutes of Health Clinical Center, Bethesda · 7 mi stran
Early Clonal Dynamics During Venetoclax Treatment for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Vključevanje udeležencevFaza 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi stran
Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- National Institutes of Health Clinical Center, Bethesda · 7 mi stran
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
Vključevanje udeležencevFaza 3
- American Oncology Partners, PA dba The Center for Cancer and Blood Disorders, Bethesda · 7 mi stran
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
Vključevanje udeležencevFaza 2
- Maryland Oncology Hematology, Silver Spring · 7 mi stran
Immune Profiling of CLL/SLL Treated With First-Line Pirtobrutinib
Vključevanje udeležencevZgodnja faza 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi stran
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Vključevanje udeležencevFaza 3
- American Oncology Partners of Maryland, PA, Bethesda · 7 mi stran
ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL
Vključevanje udeležencevFaza 3
- The Center for Cancer and Blood Disorders-Bethesda, Bethesda · 7 mi stran
Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Leukemias
Vključevanje udeležencevFaza 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 mi stran
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Vključevanje udeležencevFaza 1
- National Institute of Health, Bethesda · 7 mi stran
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Vključevanje udeležencevFaza 2
- American Oncology Partners, PA, Bethesda · 7 mi stran
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- Cancer Support Community Research & Training Institute, Washington D.C.
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
Vključevanje udeležencevFaza 3
- Maryland Oncology Hematology - Silver Spring /ID# 267557, Silver Spring · 7 mi stran
- Center for Cancer and Blood Disorders-American Oncology Partners of Maryland /ID# 266445, Bethesda · 7 mi stran
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Vključevanje udeležencevFaza 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi stran
Študije za Kronična limfocitna levkemija v drugih mestih
- Boston, MA31 študij
- Columbus, OH28 študij
- Durham, NC27 študij
- Seattle, WA20 študij
- Rochester, MN18 študij
- New York City, NY18 študij
- Houston, TX17 študij
- Baldwin Park, CA16 študij
- Milwaukee, WI15 študij
- Chicago, IL14 študij
- Cincinnati, OH14 študij
- Nashville, TN13 študij
Druge študije v Washington
- Rak (vse vrste)58 študij
- Nemalicelični pljučni rak55 študij
- Rak dojke46 študij
- Metastatski rak43 študij
- Rak pljuč41 študij
- Rak prostate38 študij
- Debelost33 študij
- Kolorektalni rak29 študij
- Srčno-žilne bolezni28 študij
- Rak mehurja26 študij
- Akutna mieločna levkemija24 študij
- Rak jajčnikov23 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.